Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Macrogenics (MGNX) Current Leases (2019 - 2025)

Macrogenics (MGNX) has disclosed Current Leases for 7 consecutive years, with $5.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Current Leases rose 6.44% to $5.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $5.2 million, a 6.44% increase, with the full-year FY2025 number at $5.2 million, up 6.44% from a year prior.
  • Current Leases was $5.2 million for Q4 2025 at Macrogenics, up from $5.1 million in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $5.4 million in Q1 2025 to a low of $3.8 million in Q4 2023.
  • A 5-year average of $4.6 million and a median of $4.7 million in 2021 define the central range for Current Leases.
  • Peak YoY movement for Current Leases: skyrocketed 36.4% in 2021, then decreased 21.81% in 2023.
  • Macrogenics' Current Leases stood at $4.7 million in 2021, then increased by 1.05% to $4.7 million in 2022, then dropped by 20.12% to $3.8 million in 2023, then increased by 28.85% to $4.9 million in 2024, then rose by 6.44% to $5.2 million in 2025.
  • Per Business Quant, the three most recent readings for MGNX's Current Leases are $5.2 million (Q4 2025), $5.1 million (Q3 2025), and $5.1 million (Q2 2025).